Laurequinone, a Lead Compound against Leishmania
Marine Drugs · 30.05.2023 · 21 (6) · 333
DOI: 10.3390/md21060333 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 30.05.2023. Verfasst von Sara García-Davis und 8 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Universitario de Bio-Orgánica Antonio González (IUBO AG), Universidad de La Laguna (ULL), Avenida Astrofísico Francisco Sánchez 2, 38206 La…. Hauptthemen laut MEDLINE: Leishmania, Leishmaniasis, Leishmania mexicana, Antiprotozoal Agents. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundación CajaCanarias, Agencia Canaria de Investigación, Innovación y Sociedad de la Información, Ministry of Health.
Abstract (Originalsprache)
Among neglected tropical diseases, leishmaniasis is one of the leading causes, not only of deaths but also of disability-adjusted life years. This disease, caused by protozoan parasites of the genus Leishmania, triggers different clinical manifestations, with cutaneous, mucocutaneous, and visceral forms. As existing treatments for this parasitosis are not sufficiently effective or safe for the patient, in this work, different sesquiterpenes isolated from the red alga Laurencia johnstonii have been studied for this purpose. The different compounds were tested in vitro against the promastigote and amastigote forms of Leishmania amazonensis. Different assays were also performed, including the measurement of mitochondrial potential, determination of ROS accumulation, and chromatin condensation, among others, focused on the detection of the cell death process known in this type of organism as apoptosis-like. Five compounds were identified that displayed leishmanicidal activity: laurequinone, laurinterol, debromolaurinterol, isolaurinterol, and aplysin, showing IC50 values against promastigotes of 1.87, 34.45, 12.48, 10.09, and 54.13 µM, respectively. Laurequinone was the most potent compound tested and was shown to be more effective than the reference drug miltefosine against promastigotes. Different death mechanism studies carried out showed that laurequinone appears to induce programmed cell death or apoptosis in the parasite studied. The obtained results underline the potential of this sesquiterpene as a novel anti-kinetoplastid therapeutic agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto Universitario de Bio-Orgánica Antonio González (IUBO AG), Universidad de La Laguna (ULL), Avenida Astrofísico Francisco Sánchez 2, 38206 La Laguna, Tenerife, Spain.
- Departamento de Química Orgánica, Universidad de La Laguna, Avenida Astrofísico Francisco Sánchez 2, 38206 La Laguna, Tenerife, Spain.
- Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, Universidad de La Laguna, Avenida Astrofísico Francisco Sánchez S/N, 38206 La Laguna, Tenerife, Spain.
- Consorcio Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), |Instituto de Salud Carlos III, 28006 Madrid, Madrid, Spain.
- Departamento de Obstetricia y Ginecología, Pediatría, Medicina Preventiva y Salud Pública, Toxicología, Medicina Legal y Forense y Parasitología, Universidad de La Laguna, 38200 La Laguna, Tenerife, Spain.
- Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, Avenida Pedro de Alba S/N, San Nicolás de los Garza 66450, Nuevo León, Mexico.
ORCID-Profile: Sara García-Davis, Atteneri López-Arencibia, Ezequiel Viveros-Valdez, Ana R Díaz-Marrero, José J Fernández, José E Piñero
Förderung
- Fundación CajaCanarias
- Agencia Canaria de Investigación, Innovación y Sociedad de la Información
- Ministry of Health
- Instituto de Salud Carlos III
- Fundación CajaCanarias–Fundación Bancaria “La Caixa”
- Programme of Requalification of the Spanish University System from Spanish Ministry for Universities, ULL, Next-Generation EU Funds
Zitieren
APA
García-Davis, S., López-Arencibia, A., Bethencourt-Estrella, C. J., San Nicolás-Hernández, D., Viveros-Valdez, E., Díaz-Marrero, A. R., Fernández, J. J., Lorenzo-Morales, J., & Piñero, J. E. (2023). Laurequinone, a Lead Compound against Leishmania. Marine Drugs, 21(6), 333. https://doi.org/10.3390/md21060333
Vancouver
García-Davis S, López-Arencibia A, Bethencourt-Estrella CJ, San Nicolás-Hernández D, Viveros-Valdez E, Díaz-Marrero AR, et al. Laurequinone, a Lead Compound against Leishmania. Marine Drugs. 2023;21(6):333. doi:10.3390/md21060333
BibTeX
@article{GarcaDavis2023,
author = {García-Davis, Sara and López-Arencibia, Atteneri and Bethencourt-Estrella, Carlos J and San Nicolás-Hernández, Desirée and Viveros-Valdez, Ezequiel and Díaz-Marrero, Ana R and Fernández, José J and Lorenzo-Morales, Jacob and Piñero, José E},
title = {Laurequinone, a Lead Compound against Leishmania},
journal = {Marine Drugs},
year = {2023},
volume = {21},
number = {6},
pages = {333},
doi = {10.3390/md21060333}
}
EUVIMED